The below graph shows an average of 319 physicians using eMPOWERx to send prescriptions between July 2006 and Sept. 2007. The number of Medicaid patients receiving prescriptions through eMPOWERx was higher at an average of 2,149 patients per month. The number of prescriptions fluctuated between 3,770 and 4,707, with an average of 4,115 per month across the 15 month period. These data show a steady level of e-prescribing activity between 2006 and 2007, stable but not increasing at any notable rate.

Prescribers who use eMPOWERx write about 20% fewer prescriptions on average than physicians who do not use the system. The below graph compares physicians who use eMPOWERx to physicians who do not use the application in terms of the average number of prescriptions written each month. These counts include electronic and paper prescriptions. Upon inspection it is clear that physicians using eMPOWERx write fewer prescriptions per patient, at an average of 2.7 prescriptions than those who do not use eMPOWERx, with an average of 3.4 prescriptions per patient. This is an average difference of 24.7% between average prescriptions written by the two physician groups during the period of July 2006 and Sept. 2007.

The below graph shows the average monthly cost savings per Medicaid patient, from July 2006 to September 2007. The savings per patient parallel the number of prescriptions written per patient, as shown in the previous graph. For the physicians using eMPOWERx, the cost per patient to Medicaid for prescriptions fluctuates between a low of $203 per patient to a high of $243 per patient, for an average of $228 per patient during the period. In contrast, for physicians not using eMPOWERx, the lowest cost per patient was $254 and the highest cost per patient was $294 in the period. The average cost per patient in this group was $276. This number is an average of $48 more per month per patient than the average cost of prescriptions among physicians who used eMPOWERx.

The below graph shows the breakdown of drug interaction alerts by High and Very High Severity compared to Moderate to Low Severity ranking, for the period between July 2006 and September 2007. As shown below, the number of drug interactions decreased markedly between 2006 and 2007; the high to very high severity interactions decreased by 41.5% and the moderate to low severity drug interactions decreased by 45%.
Drug Interaction Alerts by Severity Ranking, July 2006 - September 2007

|
|